Prenatal Safe 5
£285.00
Prenatalsafe® NIPT is a non-invasive prenatal test that enables the analysis of fetal genetic material from a
routine blood sample taken from the mother. Depending on the test chosen, it allows for the testing of aneuploidies, microdeletion syndromes and single gene disorders.
- IT'S SIMPLE
A simple blood sample at 10+ week of pregnancy, from which the circulating fetal DNA is analysed. - IT'S RELIABLE
99.9% sensitivity for trisomy 21,18 13 (Pertile et al., 2021). - IT'S SAFE
It is a non-invasive test, no risk to the fetus or the mother. - IT'S SENSITIVE
It allows detecting chromosomal aneuploidies even at low quantities of fetal DNA (2%), unlike other tests that require a quantity of fetal DNA> 4%. - IT'S QUICK
Thanks to the new high-resolution FAST technology, the PrenatalSAFE test results will be available from 3 working days (for the standard Prenatalsafe® 5 tests). - IT'S CLEAR
Prenatalsafe® is the non-invasive prenatal test that provides the clearest results: aneuploidy DETECTED or aneuploidy NOT-DETECTED, within the limits of resolution of the method
Date of Birth
Quantity
Biomarkers checked
- Down Syndrome (Trisomy 21)
- Edwards Syndrome (Trisomy 18)
- Patau Syndrome (Trisomy 13)
- Turner Syndrome (Monosomy X)
- Klinefelter Syndrome
- Jacobs Syndrome
- Gender (optional - for single or identical twins only)
Collection method
Maternal Blood
When is testing suitable?
- At or after 10 weeks: The test is performed on a maternal blood sample and is suitable for both singleton and identical twin pregnancies.
- For vanishing twins: You should wait at least 5 weeks from when the vanishing twin was detected before taking the test.
- Before 10 weeks: The test is not suitable before this time.
Laboratory processing time
Standard Turnaround time: 2-5 working days
How does it work?
1. Order Prenatal Test Kit online or from clinic
2. Receive the kit
3. Consultation with doctor
4. Produce a Maternal blood sample
5. Post the sample kit to a Post Box
6. Results via password protected email and discussion of abnormal results and recommended management plan.
7.Post-test consultation with a Clinical Scientist if high-risk result.
Accreditations
Labs are based in Italy/UK ISO 9001:2015,ISO 17025,UNI EN ISO 15189:2013
Distributed in the UK by Biox Medical Ltd
_edited.jpg)









